Nutex Historical Income Statement

NUTX Stock

USD 34.76 0.54 1.58%

Historical analysis of Nutex Health income statement accounts such as Other Operating Expenses of 293.4 M can show how well Nutex Health performed in making a profits. Evaluating Nutex Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nutex Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Nutex Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nutex Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutex Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

About Nutex Income Statement Analysis

Nutex Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nutex Health shareholders. The income statement also shows Nutex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nutex Health Income Statement Chart

At this time, Nutex Health's Gross Profit is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 293.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 26.3 M in 2024.

Selling General Administrative Total Revenue Other Operating Expenses Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Nutex Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nutex Health. It is also known as Nutex Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Nutex Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nutex Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutex Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.At this time, Nutex Health's Gross Profit is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 293.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 26.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	5.5M	18.0M	66.5M	69.9M
Cost Of Revenue	152.3M	205.8M	212.9M	223.5M

Total Operating Expenses Cost Of Revenue

Nutex Health income statement Correlations

	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Depreciation And Amortization	Interest Expense	Research Development	Net Interest Income	Selling And Marketing Expenses	Net Income From Continuing Ops	Reconciled Depreciation	Minority Interest	Tax Provision	Non Recurring	Non Operating Income Net Other
Selling General Administrative		0.57	0.81	0.38	0.51	-0.07	-0.06	0.08	0.94	0.22	-0.43	0.15	0.87	0.11	0.38	0.7	-0.27	0.06	0.14	0.27	-0.54	-0.01	-0.13	0.15
Total Revenue	0.57		0.76	0.79	0.63	-0.09	-0.05	0.69	0.62	0.02	-0.63	-0.06	0.44	0.62	0.72	0.53	-0.65	0.33	-0.08	0.76	-0.53	0.32	-0.26	0.38
Gross Profit	0.81	0.76		0.37	0.89	0.26	0.27	0.15	0.72	0.49	-0.24	0.4	0.76	0.1	0.3	0.58	-0.16	-0.18	0.39	0.22	-0.87	-0.07	-0.02	-0.01
Other Operating Expenses	0.38	0.79	0.37		0.08	-0.33	-0.28	0.95	0.61	-0.31	-0.92	-0.35	0.08	0.95	0.99	0.49	-0.97	0.82	-0.38	0.94	0.03	0.35	-0.74	0.73
Operating Income	0.51	0.63	0.89	0.08		0.4	0.4	-0.04	0.34	0.56	0.11	0.48	0.62	-0.16	-0.02	0.32	0.15	-0.49	0.47	-0.01	-0.96	-0.05	0.31	-0.32
Ebit	-0.07	-0.09	0.26	-0.33	0.4		1.0	-0.36	-0.07	0.95	0.47	0.96	-0.16	-0.35	-0.37	-0.07	0.45	-0.57	0.96	-0.44	-0.37	-0.88	0.04	-0.04
Ebitda	-0.06	-0.05	0.27	-0.28	0.4	1.0		-0.31	-0.05	0.94	0.43	0.96	-0.17	-0.3	-0.32	-0.05	0.4	-0.53	0.95	-0.39	-0.36	-0.87	-0.01	0.01
Cost Of Revenue	0.08	0.69	0.15	0.95	-0.04	-0.36	-0.31		0.32	-0.43	-0.83	-0.46	-0.17	0.98	0.93	0.3	-0.94	0.84	-0.48	0.93	0.18	0.44	-0.69	0.69
Total Operating Expenses	0.94	0.62	0.72	0.61	0.34	-0.07	-0.05	0.32		0.16	-0.64	0.11	0.67	0.39	0.62	0.72	-0.52	0.34	0.08	0.47	-0.35	-0.07	-0.46	0.45
Income Before Tax	0.22	0.02	0.49	-0.31	0.56	0.95	0.94	-0.43	0.16		0.43	0.99	0.15	-0.42	-0.36	0.08	0.46	-0.64	0.99	-0.45	-0.57	-0.85	0.11	-0.11
Total Other Income Expense Net	-0.43	-0.63	-0.24	-0.92	0.11	0.47	0.43	-0.83	-0.64	0.43		0.45	-0.14	-0.88	-0.94	-0.49	0.95	-0.88	0.47	-0.89	-0.17	-0.35	0.73	-0.75
Net Income	0.15	-0.06	0.4	-0.35	0.48	0.96	0.96	-0.46	0.11	0.99	0.45		0.08	-0.44	-0.39	0.03	0.48	-0.62	1.0	-0.48	-0.49	-0.9	0.08	-0.08
Income Tax Expense	0.87	0.44	0.76	0.08	0.62	-0.16	-0.17	-0.17	0.67	0.15	-0.14	0.08		-0.2	0.07	0.47	0.02	-0.24	0.08	0.02	-0.71	0.17	0.27	-0.27
Depreciation And Amortization	0.11	0.62	0.1	0.95	-0.16	-0.35	-0.3	0.98	0.39	-0.42	-0.88	-0.44	-0.2		0.96	0.31	-0.97	0.91	-0.46	0.93	0.27	0.35	-0.8	0.79
Interest Expense	0.38	0.72	0.3	0.99	-0.02	-0.37	-0.32	0.93	0.62	-0.36	-0.94	-0.39	0.07	0.96		0.5	-0.98	0.88	-0.41	0.94	0.12	0.33	-0.78	0.77
Research Development	0.7	0.53	0.58	0.49	0.32	-0.07	-0.05	0.3	0.72	0.08	-0.49	0.03	0.47	0.31	0.5		-0.36	0.23	0.0	0.32	-0.23	0.05	-0.3	0.23
Net Interest Income	-0.27	-0.65	-0.16	-0.97	0.15	0.45	0.4	-0.94	-0.52	0.46	0.95	0.48	0.02	-0.97	-0.98	-0.36		-0.93	0.5	-0.96	-0.22	-0.39	0.77	-0.8
Selling And Marketing Expenses	0.06	0.33	-0.18	0.82	-0.49	-0.57	-0.53	0.84	0.34	-0.64	-0.88	-0.62	-0.24	0.91	0.88	0.23	-0.93		-0.64	0.83	0.56	0.39	-0.79	0.79
Net Income From Continuing Ops	0.14	-0.08	0.39	-0.38	0.47	0.96	0.95	-0.48	0.08	0.99	0.47	1.0	0.08	-0.46	-0.41	0.0	0.5	-0.64		-0.5	-0.5	-0.89	0.11	-0.11
Reconciled Depreciation	0.27	0.76	0.22	0.94	-0.01	-0.44	-0.39	0.93	0.47	-0.45	-0.89	-0.48	0.02	0.93	0.94	0.32	-0.96	0.83	-0.5		0.1	0.46	-0.58	0.75
Minority Interest	-0.54	-0.53	-0.87	0.03	-0.96	-0.37	-0.36	0.18	-0.35	-0.57	-0.17	-0.49	-0.71	0.27	0.12	-0.23	-0.22	0.56	-0.5	0.1		0.09	-0.37	0.38
Tax Provision	-0.01	0.32	-0.07	0.35	-0.05	-0.88	-0.87	0.44	-0.07	-0.85	-0.35	-0.9	0.17	0.35	0.33	0.05	-0.39	0.39	-0.89	0.46	0.09		0.15	-0.15
Non Recurring	-0.13	-0.26	-0.02	-0.74	0.31	0.04	-0.01	-0.69	-0.46	0.11	0.73	0.08	0.27	-0.8	-0.78	-0.3	0.77	-0.79	0.11	-0.58	-0.37	0.15		-0.8
Non Operating Income Net Other	0.15	0.38	-0.01	0.73	-0.32	-0.04	0.01	0.69	0.45	-0.11	-0.75	-0.08	-0.27	0.79	0.77	0.23	-0.8	0.79	-0.11	0.75	0.38	-0.15	-0.8

Click cells to compare fundamentals

Nutex Health Account Relationship Matchups

Nutex Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Selling General Administrative	59.9M	115.1M	5.5M	18.0M	33.2M	26.3M
Total Revenue	97.1M	273.4M	331.5M	219.3M	247.6M	129.0M
Gross Profit	95.4M	271.6M	179.3M	13.5M	34.8M	54.7M
Other Operating Expenses	62.3M	121.1M	157.7M	223.9M	279.4M	293.4M
Operating Income	34.7M	152.3M	170.3M	(5.1M)	(31.8M)	(30.2M)
Ebit	(7.0M)	(5.4M)	175.7M	(407.2M)	(32.2M)	(33.8M)
Ebitda	(6.8M)	(5.1M)	183.4M	(394.0M)	(14.6M)	(15.3M)
Cost Of Revenue	1.7M	1.8M	152.3M	205.8M	212.9M	223.5M
Total Operating Expenses	62.3M	121.1M	5.5M	18.0M	66.5M	69.9M
Income Before Tax	32.1M	145.6M	169.5M	(419.6M)	(48.5M)	(46.1M)
Total Other Income Expense Net	(2.6M)	(7.4M)	(773.9K)	(13.0M)	(16.7M)	(15.9M)
Net Income	16.5M	106.0M	132.6M	(432.7M)	(45.8M)	(43.5M)
Income Tax Expense	15.6M	50.8M	965.7K	13.1M	(5.1M)	(4.8M)
Depreciation And Amortization	179.5K	236.5K	7.8M	13.2M	17.6M	18.5M
Interest Expense	3.5M	6.4M	6.2M	12.5M	16.3M	17.1M
Research Development	545.2K	768.1K	557.3K	285.9K	328.8K	480.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nutex Historical Income Statement

About Nutex Income Statement Analysis

Nutex Health Income Statement Chart

Total Revenue

Other Operating Expenses

Nutex Health income statement Correlations

Nutex Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nutex Health income statement Accounts

Also Currently Popular

Additional Tools for Nutex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Net Income From Continuing Ops	+ 1.0	Net Income
Interest Expense	+ 0.99	Other Operating Expenses
Net Income	+ 0.99	Income Before Tax
Net Income From Continuing Ops	+ 0.99	Income Before Tax
Depreciation And Amortization	+ 0.98	Cost Of Revenue

Net Interest Income	- 0.98	Interest Expense
Net Interest Income	- 0.97	Depreciation And Amortization
Net Interest Income	- 0.97	Other Operating Expenses
Reconciled Depreciation	- 0.96	Net Interest Income
Minority Interest	- 0.96	Operating Income
Interest Expense	- 0.94	Total Other Income Expense Net